Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is spotlighting its RADiant treatment system at the American Academy of Dermatology (AAD) annual meeting in Washington from March 1st to 5th.
The RADiant system is a small and compact unit specifically designed for use by dermatologists.
RADiant is a dual modality treatment system offering both superficial radiotherapy and electronic brachytherapy treatment options.
"RADiant expands the dermatologists' non-melanoma skin cancer treatment options with the latest dual modality radiotherapy technology," says Adrian Treverton, CEO of Xstrahl. "RADiant offers an extremely effective treatment option for when Mohs is not available, or the patient is unsuitable for surgery."
With the RADiant system, treatment delivery is fast, convenient and pain free. Patient visit time is kept to a minimum, typically 15 minutes including setup and treatment, leaving them free to continue with their normal daily activities. Advanced features such as illuminated halo applicators and an intuitive clinical dashboard provide physicians with meticulous control to deliver superior, surgical quality results.
For ore details, http://www.xstrahl.com
.